Bosh sahifa000100 ā¢ KRX
add
Yuhan Corp
Yopilish kursi
94Ā 700,00Ā ā©
Kunlik diapazon
94Ā 600,00Ā ā© - 95Ā 600,00Ā ā©
Yillik diapazon
90Ā 900,00Ā ā© - 136Ā 400,00Ā ā©
Bozor kapitalizatsiyasi
7,65Ā trln KRW
OŹ»rtacha hajm
200,85Ā ming
Narx/foyda
36,47
Dividend daromadliligi
0,63%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 546,07Ā mlrd | 10,07% |
Joriy xarajat | 185,79Ā mlrd | 17,50% |
Sof foyda | 114,43Ā mlrd | 1Ā 094,12% |
Sof foyda marjasi | 20,96 | 1Ā 003,45% |
Har bir ulushga tushum | 1,53Ā ming | 1Ā 094,81% |
EBITDA | 44,17Ā mlrd | 844,26% |
Amaldagi soliq stavkasi | 8,91% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 378,08Ā mlrd | 14,33% |
Jami aktivlari | 3,22Ā trln | 9,48% |
Jami passivlari | 858,64Ā mlrd | 8,50% |
Umumiy kapital | 2,36Ā trln | ā |
Tarqatilgan aksiyalar | 74,76Ā mln | ā |
Narxi/balansdagi bahosi | 3,07 | ā |
Aktivlardan daromad | 2,15% | ā |
Kapitaldan daromad | 2,57% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 114,43Ā mlrd | 1Ā 094,12% |
Operatsiyalardan naqd pul | 7,70Ā mlrd | -85,62% |
Sarmoyadan naqd pul | -11,78Ā mlrd | 38,27% |
Moliyadan naqd pul | -2,68Ā mlrd | -107,14% |
Naqd pulning sof oŹ»zgarishi | -8,29Ā mlrd | -110,81% |
BoŹ»sh pul | -68,14Ā mlrd | -2Ā 056,14% |
Haqida
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
CEO
Tashkil etilgan
1926
Sayt
Xodimlar soni
2Ā 067
